Yotsumoto S, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M
Immunology Division, Jichi Medical School, Tochigi-Ken, Japan.
J Virol Methods. 1990 May;28(2):107-16. doi: 10.1016/0166-0934(90)90024-a.
The S-gene fragments of hepatitis B virus (HBV) DNA in serum, or integrated in chromosomes of human hepatoma cells (PLC/PRF/5), were amplified by the polymerase chain reaction, cloned into an M13 phage vector, and then sequenced only for adenine. The subtype determinant d or y was established by the presence or absence of adenine as nucleotide 365, and w or r by that of nucleotide 479 in the S gene. The results were identical with those obtained by enzyme immunoassay with monoclonal antibodies. A high sensitivity for the detection of HBV DNA, amplified by the polymerase chain reaction, allowed subtyping of HBV in sera containing HBsAg in concentrations too low to be subtyped by immunological methods. Furthermore, subtyping at the nucleotide level can be applied to tissues containing HBV DNA sequences in integrated forms, such as hepatocellular carcinomas, stored frozen or in formalin.
血清中或整合到人肝癌细胞(PLC/PRF/5)染色体中的乙肝病毒(HBV)DNA的S基因片段,通过聚合酶链反应进行扩增,克隆到M13噬菌体载体中,然后仅对腺嘌呤进行测序。根据S基因中第365位核苷酸是否为腺嘌呤确定亚型决定簇d或y,根据第479位核苷酸确定w或r。结果与用单克隆抗体进行酶免疫测定所获得的结果一致。聚合酶链反应扩增HBV DNA具有高灵敏度,可对血清中HBsAg浓度过低而无法用免疫方法进行亚型分型的HBV进行亚型分型。此外,核苷酸水平的亚型分型可应用于含有整合形式HBV DNA序列的组织,如冷冻保存或用福尔马林固定的肝细胞癌。